Guardant Health
GH
#1449
Rank
HK$119.38 B
Marketcap
HK$900.32
Share price
17.09%
Change (1 day)
187.73%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): -HK$26.48

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -HK$26.55. In 2025 the company made an earnings per share (EPS) of -HK$25.92 an increase over its 2024 EPS that were of -HK$27.88.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$26.482.17%
2025-HK$25.92-7.02%
2024-HK$27.88-16.82%
2023-HK$33.52-33.13%
2022-HK$50.1260%
2021-HK$31.3255.04%
2020-HK$20.20207.14%
2019-HK$6.58-19.81%
2018-HK$8.20

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-HK$21.98-17.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-HK$19.42-26.84%๐Ÿ‡บ๐Ÿ‡ธ USA